Person | Jotup

DRAFTKINGS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against DraftKings Inc. and Encourages Investors to Contact the Firm

Retrieved on:

Wednesday, March 22, 2023

Class Action Lawsuit, Professional Services, Legal, Telephone, P.C, Court, DKNG, Jeanne Eagels, District court, Non-fungible token, DraftKings, Person

Investors have until May 8, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points:

Investors have until May 8, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Click here to participate in the action.
When the true details entered the market, the lawsuit claims that investors suffered damages.
There is no cost or obligation to you.

Liberty Gold Files Technical Report on SEDAR for Updated Resource Estimate at Black Pine Oxide Gold Deposit, Great Basin, USA

Retrieved on:

Wednesday, March 22, 2023

LGD, Technical report, Person, CPG, National instrument, NI, SEDAR, OTCQX, National Instrument 43-101, TSX, Technical Report Archive & Image Library, Mineral resource estimation, News, Cryptocurrency

VANCOUVER, British Columbia, March 21, 2023 (GLOBE NEWSWIRE) -- Liberty Gold Corp. (TSX: LGD; OTCQX: LGDTF) (“Liberty Gold” or the “Company”) is pleased to announce that further to its news release dated February 7, 2023, the Company has filed on SEDAR a National Instrument (“NI”) 43-101 Technical Report for the Black Pine Oxide Gold Property in southeastern Idaho, USA.

Key Points:

VANCOUVER, British Columbia, March 21, 2023 (GLOBE NEWSWIRE) -- Liberty Gold Corp. (TSX: LGD; OTCQX: LGDTF) (“Liberty Gold” or the “Company”) is pleased to announce that further to its news release dated February 7, 2023, the Company has filed on SEDAR a National Instrument (“NI”) 43-101 Technical Report for the Black Pine Oxide Gold Property in southeastern Idaho, USA.
The NI 43-101 Technical Report is entitled “Technical Report on the Updated Mineral Resource Estimate at the Black Pine Gold Project, Cassia and Oneida Counties, Idaho, USA”, effective January 21, 2023, and signed March 10, 2023 (the “Technical Report”).
The Technical Report was prepared in accordance with National Instrument 43-101 – Standards of Disclosure for Mineral Projects by Ryan Rodney, CPG, of SLR International Corporation of Denver, Colorado; Gary L. Simmons of GL Simmons Consulting LLC of Larkspur, Colorado, both independent Qualified Persons under National Instrument 43-101; and Moira Smith, Ph.D., P.Geo., of Liberty Gold Corp.
Peter Shabestari, P.Geo., Vice-President Exploration, Liberty Gold, is the Company’s designated Qualified Person for this news release within the meaning of National Instrument 43-101 Standards of Disclosure for Mineral Projects (“NI 43-101”) and has reviewed and validated that the information contained in the release is accurate.

FATE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Fate Therapeutics, Inc. and Encourages Investors to Contact the Firm

Retrieved on:

Wednesday, March 22, 2023

Investors have until March 22, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points:

Investors have until March 22, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Fate is a clinical-stage biopharmaceutical company that develops programmed cellular immunotherapies to treat cancer and immune disorders.
Throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and compliance policies.
On January 5, 2023, after the markets closed, Fate issued a press release announcing that it had terminated the Janssen Collaboration Agreement.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Rite Aid (RAD) Investors with Substantial Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Filed

Retrieved on:

Tuesday, March 21, 2023

Controlled Substances Act, Justice, RAD, Rite Aid, Person, DOJ, Ground substance, Prescription, False Claims Act, Complaint, Accusative case, Pharmacist, Hagens Berman, SAN, News, NYSE, Rite, Safety, Pharmaceutical industry

SAN FRANCISCO, March 21, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Rite Aid Corporation (NYSE: RAD) investors who suffered substantial losses to submit your losses now .

Key Points:

SAN FRANCISCO, March 21, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Rite Aid Corporation (NYSE: RAD) investors who suffered substantial losses to submit your losses now .
Rite Aid Corporation (RAD) Securities Fraud Class Action:
The litigation focuses on Rite Aid’s compliance with federal regulations concerning its pharmacies’ prescriptions practices and its federal healthcare program reimbursement billing.
If you invested in Rite Aid and have substantial losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .
Whistleblowers: Persons with non-public information regarding Rite Aid should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against United Natural Foods, Inc. (UNFI)

Retrieved on:

Tuesday, March 21, 2023

Class Action Lawsuit, Professional Services, Legal, UNFI, Complaint, United Natural Foods, Data management, Deception, News, NYSE, Person, Security (finance)

The Class: Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired United Natural Foods, Inc. (NYSE: UNFI) securities between March 10, 2021 and March 7, 2023, for violations of the Securities Exchange Act of 1934.

Key Points:

The Class: Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired United Natural Foods, Inc. (NYSE: UNFI) securities between March 10, 2021 and March 7, 2023, for violations of the Securities Exchange Act of 1934.
United Natural Foods is a distributor of natural, organic, specialty, produce, and conventional grocery and non-food products.
What Now: Similarly situated shareholders may be eligible to participate in the class action against United Natural Foods.
Shareholders who want to act as lead plaintiff for the class must file their papers by May 19, 2023.

Credit Suisse Group AG (CS) Equity Alert: Contact Robbins LLP for Information Regarding the Credit Suisse Class Action

Retrieved on:

Tuesday, March 21, 2023

Lehmann, Reuters, Interview, ADS, Swiss Financial Market Supervisory Authority, CS, Person, Credit Suisse, Complaint, Financial Times, Risk, Credit, News, NYSE, Bloomberg Television, Security (finance), Cryptocurrency

What Now: Similarly situated shareholders may be eligible to participate in the class action against Credit Suisse.

Key Points:

What Now: Similarly situated shareholders may be eligible to participate in the class action against Credit Suisse.
Shareholders who want to act as lead plaintiff for the class must file their papers by May 8, 2023.
A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
On this news, Credit Suisse’s ADS price rose $0.29 per ADS, or 9.36%, to close at $3.38 per ADS on December 2, 2022.

Pregnancy Outcomes with COVID-19 Vaccines Reviewed in Journal of American Physicians and Surgeons (AAPS)

Retrieved on:

Tuesday, March 21, 2023

Their summary is published in the spring issue of the peer-reviewed Journal of American Physicians and Surgeons.

Key Points:

Their summary is published in the spring issue of the peer-reviewed Journal of American Physicians and Surgeons.
Influenza vaccines were chosen as the control group because the CDC first approved influenza vaccines for pregnant women in 1997.
The study period provides 282 months of data for the influenza vaccine and 18 months of data for the COVID-19 vaccines.
The Journal of American Physicians and Surgeons is published by the Association of American Physicians and Surgeons (AAPS) , a national organization representing physicians in all specialties since 1943.

Signature Bank (SBNY) Class Action Alert: Robbins LLP Urges Investors with Large Losses to Contact the Firm for Information about the Signature Bank Class Action

Retrieved on:

Tuesday, March 21, 2023

Financial services, Deception, Bank failure, Person, Complaint, SAN, Signature Bank, DFS, Security (finance)

Signature Bank purports to be a “New York-based full-service commercial bank with 40 private client offices located throughout the metropolitan New York area, as well as those in Connecticut, California, Nevada and North Carolina."

Key Points:

Signature Bank purports to be a “New York-based full-service commercial bank with 40 private client offices located throughout the metropolitan New York area, as well as those in Connecticut, California, Nevada and North Carolina."
What Now: Similarly situated shareholders may be eligible to participate in the class action against Signature Bank.
Shareholders who want to act as lead plaintiff for the class must file their papers by May 15, 2023.
A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Alphabet, Inc. (GOOG, GOOGL) Shareholder Alert: Robbins LLP Reminds Investors of Class Action Against Alphabet, Inc.

Retrieved on:

Tuesday, March 21, 2023

Advertising, Justice, Impact, Use of Free and Open-Source Software (FOSS) in the U.S. Department of Defense, GOOGL, Business, U.S. Department of Justice Office of Legislative Affairs, Clayton Antitrust Act of 1914, Person, Complaint, GOOG, Nature, Risk, SAN, Sherman, Alphabet Inc., News

SAN DIEGO, March 21, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Alphabet Inc. (NASDAQ: GOOG, GOOGL) securities between February 4, 2020 and January 23, 2022, for violations of the Securities Exchange Act of 1934. Alphabet Inc. is a multinational technology conglomerate holding company. It is the parent company of Google, which is a dominant player in the field of digital advertising.

Key Points:

It is the parent company of Google, which is a dominant player in the field of digital advertising.
What Now: Similarly situated shareholders may be eligible to participate in the class action against Alphabet.
Shareholders who want to act as lead plaintiff for the class must file their papers by May 15, 2023.
A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Amgen Inc. (AMGN) Class Action Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Amgen Inc.

Retrieved on:

Tuesday, March 21, 2023

Class Action Lawsuit, Professional Services, Legal, Government, Complaint, AMGN, Tax, Impact, Person, Security (finance), Amgen

Amgen is one of the world’s largest independent biopharmaceutical companies.

Key Points:

Amgen is one of the world’s largest independent biopharmaceutical companies.
What Now: Similarly situated shareholders may be eligible to participate in the class action against Amgen.
Shareholders who want to act as lead plaintiff for the class must file their papers by May 12, 2023.
A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.